Page 13 - Read Online

Page 8 of 8 Wartena et al. J Cancer Metastasis Treat 2018;4:59 I http://dx.doi.org/10.20517/2394-4722.2018.66

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Greene-Schloesser D, Moore E, Robbins ME. Molecular pathways: radiation-induced cognitive impairment. Clin Cancer Res 2013;19:2294-
300.
2. Welzel G, Fleckenstein K, Schaefer J, Hermann B, Kraus-Tiefenbacher U, et al. Memory function before and after whole brain radiotherapy
in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 2008;72:1311-8.
3. Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with
brain tumours. Nat Rev Neurol 2017;13:52-64.
4. Pereira Dias G, Hollywood R, Bevilaqua MC, da Luz AC, Hindges R, et al. Consequences of cancer treatments on adult hippocampal
neurogenesis: implications for cognitive function and depressive symptoms. Neuro Oncol 2014;16:476-92.
5. Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002;8:955-62.
6. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, et al. Memantine for the prevention of cognitive dysfunction in patients receiving
whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 2013;15:1429-37.
7. Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease. CNS Drug
Rev 2003;9:275-308.
8. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, et al. Vitamin E and donepezil for the treatment of mild cognitive
impairment. N Engl J Med 2005;352:2379-88.
9. Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, et al. Safety and efficacy of methylphenidate for apathy in Alzheimer’s
disease: a randomized, placebo-controlled trial. J Clin Psychiatry 2013;74:810-6.
10. Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, et al. Short-term efficacy of methylphenidate: a randomized, double-blind,
placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004;22:4795-803.
11. Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, et al. Donepezil for irradiated brain tumor survivors: a phase III randomized
placebo-controlled clinical trial. J Clin Oncol 2015;33:1653-9.
12. Levels of evidence. BJU Int 2011;107:870.
13. Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical
trial of d-threo-methylphenidate HCI in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 2007;69:1496-501.
14. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor
patients. J Clin Oncol 1998;16:2522-7.
15. Shaw EG, Rosdhal R, D’Agostino RB Jr, Lovato J, Naughton MJ, et al. Phase II study of donepezil in irradiated brain tumor patients: effect
on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415-20.
16. Correa DD, Kryza-Lacombe M, Baser RE, Beal K, DeAngelis LM. Cognitive effects of donepezil therapy in patients with brain tumors: a
pilot study. J Neurooncol 2016;127:313-9.
17. Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, et al. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor
donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer 2012;59:540-7.
18. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, et al. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung
cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer 2005;13:66-9.
19. Attia A, Page BR, Lesser GJ, Chan M. Treatment of radiation-induced cognitive decline. Curr Treat Options Oncol 2014;15:539-50.